IDH1 and glioblastoma: For this, we utilized the 45 radiomic features for 200 IDH1 wild-type GBM patients (71 from TCGA and 129 from MUHC, Figure 1A) and considered the median value for each feature to separate patients into groups (i.e., greater than median vs. less than median).